Athersys Reports Third Quarter 2023 Financial Results and Business Highlights
Athersys
Biotechnology Research
Cleveland, OH 5,499 followers
Committed to developing therapies to extend and enhance the quality of life.
About us
Athersys is a clinical stage biopharmaceutical company with a growing pipeline of highly differentiated, potential best in class therapeutics to treat significant and life-threatening diseases. We are engaged in the discovery and development of innovative new medicines designed to extend and enhance the quality of human life. Through the application of our proprietary technologies, we have established a pipeline of therapeutic product development programs in multiple disease areas. This pipeline includes both stem cell therapy and pharmaceuticals.
- Website
-
http://www.athersys.com/
External link for Athersys
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Cleveland, OH
- Type
- Public Company
- Founded
- 1995
- Specialties
- stem cells and regenerative medicine
Locations
-
Primary
Get directions
3201 Carnegie Ave
Cleveland, OH 44115, US
Employees at Athersys
Updates
-
Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives https://buff.ly/3Q2856i
-
Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios
Athersys Reports Interim Analysis Results of MASTERS-2 Clinical Study with MultiStem in Ischemic Stroke, Signs Memorandum of Understanding (MOU) for Global ARDS License with Healios
businesswire.com
-
We're excited for Alliance for Regenerative Medicine's #CGMesa23 next week! Looking forward to connecting with senior executives and key stakeholders in the cell and gene therapy industry. Learn more: https://lnkd.in/eiUpMy4
Cell & Gene Meeting on the Mesa
https://meetingonthemesa.com
-
Athersys Licenses its Animal Health Assets to Ardent Animal Health
Athersys Licenses its Animal Health Assets to Ardent Animal Health
businesswire.com
-
We are excited to announce that Jane Wasman, JD, has been appointed Athersys Board Chair. Read more here: https://buff.ly/3F2IxB0
-
-
We hosted our 2023 Annual Meeting of Stockholders yesterday. In case you missed it, you can listen to a replay here -
ATHERSYS, INC.'s Virtual Shareholder's Meeting - Thank you page
east.virtualshareholdermeeting.com
-
Our Annual Meeting will begin at 8:30 a.m. ET this morning. Stockholders and guests can join beginning now here:
ATHERSYS, INC.'s Virtual Shareholder's Meeting - Pre meeting message page
east.virtualshareholdermeeting.com
-
Tomorrow is our Annual Meeting of Stockholders. The meeting will begin at 8:30 a.m. ET. If you're a stockholder, please have your control number ready. Both stockholders and guests can join 15 minutes prior to the start of the meeting.
ATHERSYS, INC.'s Virtual Shareholder's Meeting - Pre meeting message page
east.virtualshareholdermeeting.com
-
THE AMERICAN HEART & STROKE ASSOCIATION has a number of great resources for stroke patients and caregivers, including a directory of local support groups. Find the support group nearest to you here: https://buff.ly/3LzV7LP
-